Profile data is unavailable for this security.
About the company
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing generic pharmaceuticals. The Company operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The BPD segment distributes medically differentiated specialty products in United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The Company's products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.
- Revenue in AUD (TTM)278.45m
- Net income in AUD-258.82m
- Incorporated2005
- Employees900.00
- LocationMayne Pharma Group Ltd1538 Main North RdADELAIDE 5106AustraliaAUS
- Phone+61 88209-2666
- Fax+61 88281-0284
- Websitehttp://www.maynepharma.com/